NCT06615609Recruiting
"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients
Source: ClinicalTrials.gov · Last updated 8 Dec 2025
Brief summary (registry, in English)
This study aims to evaluate the effect of an AI-assisted "Smart family doctor" digital health management tool on improving the control rates of hypertension, diabetes, and dyslipidemia in post-CABG (coronary artery bypass grafting) patients or post-PCI (percutaneous coronary intervention) patients. A randomized controlled trial design will be used, involving approximately 5-10 hospitals and 536 participants. Eligible participants are adults aged 18 or older, post-CABG or post-PCI patients with hypertension, diabetes, and dyslipidemia.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 536 (estimated)
- First submitted
- 21 Sept 2024
- Start date
- 24 Sept 2025
- Primary completion date
- 15 Sept 2026
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Diseases
- High blood pressure
- NCT number
- NCT06615609
What you commit to
- Study type: Interventional
- Planned participants: 536
- From 24 Sept 2025 to the primary completion date, 15 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of heart failure or severe arrhythmias.
- Presence of other severe underlying conditions such as cancer or liver and kidney insufficiency.
Other
- Pregnancy, lactation, or plans for pregnancy within the next year.
- Cognitive, communication impairments, or limitations in daily activities.
Who the study is looking for
- Age ≥ 18 years.
- History of CABG surgery or PCI with history of hypertension, diabetes, and dyslipidemia.
- At least one of the following criteria is meet:
- Systolic blood pressure no less than 130 mmHg or diastolic blood pressure no less than 80 mmHg
- HbA1c no less than 7%
- LDL-C no less than 1.4 mmol/L
- Use of a smartphone.
- Signed informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Xinjiang's First Affiliated Hospital of medical university Coordinator of this site? Confirm its status | Ürümqi | China | Recruiting |
Related publications
- Design and rationale of the artificial intelligent dialogue System assisted comprehensive Management of secondary prevention Among post coronary aRtery bypass graft patienTs (SMART): protocol for a randomised controlled trial for postcoronary artery bypass grafting management.BMJ Open · 2025 · PMID 41218945
This page is information, not medical advice. Discuss any trial with your doctor.